Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
16
EDIT Quote, Financials, Valuation and Earnings
Last price:
$2.21
Seasonality move
:
-10.7%
Day range:
$2.17 - $2.24
52-week range:
$0.91 - $4.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.05x
P/B ratio:
16.04x
Volume:
702.3K
Avg. volume:
1.7M
1-year change:
82.64%
Market cap:
$215.7M
Revenue:
$32.3M
EPS (TTM):
-$2.38
Earnings Data
Next earnings date for EDIT
Mar 11
2026
Most recent earnings per share
-$0.28
Beat by $0.11
(Nov 10/2025)
Consensus Estimate
-$0.38
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
EDIT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/11/2026 | Q4 | $8.5M | -- | -- | -$0.21 | -- |
| 11/10/2025 | Q3 | $4.9M | $7.5M | -$0.28 | -$0.38 | $0.11 |
| 08/12/2025 | Q2 | $1.8M | $3.6M | -$0.63 | -$0.38 | -$0.25 |
| 05/07/2025 | Q1 | $706.1K | $4.7M | -$0.92 | -$0.59 | -$0.32 |
| 03/05/2025 | Q4 | $37.2M | $30.6M | -$0.55 | -$0.33 | -$0.22 |
| 11/04/2024 | Q3 | $3.9M | $61K | -$0.75 | -$0.77 | $0.02 |
| 08/07/2024 | Q2 | $4.1M | $513K | -$0.82 | -$0.71 | -$0.11 |
| 05/08/2024 | Q1 | $7.3M | $1.1M | -$0.76 | -$0.64 | -$0.12 |
| 02/28/2024 | Q4 | $14.3M | $60M | -$0.23 | -$0.48 | $0.25 |
| 11/03/2023 | Q3 | -- | -- | -$0.55 | -$0.58 | $0.03 |
| 08/02/2023 | Q2 | -- | -- | -$0.56 | -$0.77 | $0.21 |
| 05/05/2023 | Q1 | -- | -- | -$0.71 | -$0.81 | $0.10 |
| 02/22/2023 | Q4 | -- | -- | -$0.88 | -$0.81 | -$0.07 |
| 11/02/2022 | Q3 | -- | -- | -$0.81 | -$0.85 | $0.04 |
| 08/03/2022 | Q2 | -- | -- | -$0.78 | -$0.80 | $0.02 |
| 05/04/2022 | Q1 | -- | -- | -$0.74 | -$0.79 | $0.05 |
| 02/24/2022 | Q4 | -- | -- | -$0.61 | -$0.73 | $0.12 |
| 11/08/2021 | Q3 | -- | -- | -$0.57 | -$0.81 | $0.24 |
| 08/04/2021 | Q2 | -- | -- | -$0.81 | -$0.81 | $0.00 |
| 05/05/2021 | Q1 | -- | -- | -$0.86 | -$0.71 | -$0.15 |
| 02/25/2021 | Q4 | -- | -- | -$1.00 | -$0.88 | -$0.12 |
| 11/05/2020 | Q3 | -- | -- | $0.12 | -$0.63 | $0.75 |
| 08/06/2020 | Q2 | -- | -- | -$0.43 | -$0.82 | $0.39 |
| 05/07/2020 | Q1 | -- | -- | -$0.69 | -$0.81 | $0.12 |
| 02/26/2020 | Q4 | -- | -- | -$0.74 | $0.06 | -$0.80 |
| 11/12/2019 | Q3 | -- | -- | -$0.66 | -$0.73 | $0.07 |
| 08/06/2019 | Q2 | -- | -- | -- | -$0.62 | -- |
| 05/07/2019 | Q1 | -- | -- | -- | -$0.64 | -- |
| 02/28/2019 | Q4 | -- | -- | -- | -$0.55 | -- |
| 11/07/2018 | Q3 | -- | -- | -- | -$0.81 | -- |
| 08/06/2018 | Q2 | -- | -- | -- | -- | -- |
| 05/03/2018 | Q1 | -- | -- | -- | -- | -- |
| 03/06/2018 | Q4 | -- | -- | -- | -- | -- |
| 11/07/2017 | Q3 | -- | -- | -- | -- | -- |
| 08/09/2017 | Q2 | -- | -- | -- | -- | -- |
| 05/15/2017 | Q1 | -- | -- | -- | -- | -- |
| 03/07/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/07/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/16/2016 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -- | -- | -- |
Editas Medicine, Inc. Earnings Questions
-
How Much did Editas Medicine, Inc. Generate in Revenue Last Quarter?
Editas Medicine, Inc. reported $7.5M worth of top line sales in its most recent quarter.
-
Did Editas Medicine, Inc. Beat Earnings Last Quarter?
Editas Medicine, Inc. announced earnings per share of -$0.28 which represents a beat of analyst forecast a -$0.38 per share.
-
Is Editas Medicine, Inc. Profitable?
Editas Medicine, Inc. reported $6.8M that represents $0.08 per share over the last quarter.
-
What is the Analyst Consensus for Editas Medicine, Inc. EPS Next Year?
Editas Medicine, Inc.'s earnings are forecast to decrease from -$2.88 per share to -$2.65 per share next year representing a decrease of -32.06%.
-
When is Editas Medicine, Inc.'s Earnings Date?
Editas Medicine, Inc.'s next earnings date is March 11, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
